RxDoctor Payments Data

Souheil Moussly

Internal Medicine · Port Orange, FLNPI 1063524577

Payments from drug & device makers

$236,071in general payments, 2019–2025

Across 138 payments — averaging $1710.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$213K
  • Vifor (international) Ltd.$22K
  • AstraZeneca$565
  • Novo Nordisk$210
  • GSK$200
  • Lilly USA, LLC$166
  • plus $646 from 13 others
$14,409in research payments, 2019–2025

Across 5 payments — averaging $2881.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$14K

What the payments were for

  • Food & beverage$1,781100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$236,071 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Other internal medicine in Port Orange

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →